The clinical manifestations of gastric cancer are imperceptible. Most cases are diagnosed at advanced stage, with a relatively high proportion [1] . After decades of evolution, gastric cancer surgical techniques have been gradually improved, but the 5year survival rate of gastric cancer patients after radical resection is still about 30% [2] , and the 5year survival rate of stage IV gastric cancer patients is even lower [3] . In order to investigate the prognostic factors of stage IV gastric cancer patients, we retrospectively analyzed 630 cases of stage IV gastric cancer without distant metastasis, explored the correlations of clinicopathologic features of stage IV gastric cancer to its prognosis.
Between January 1993 and August 2004, 630 patients with stage IV gastric cancer without distant metastasis (T13N3M0, T4N2M0) were treated at the Department of Gastrointestinal Surgery of Harbin Medical University Cancer Hospital. Inclusion criteria were as follows: (1) the primary tumor was removed, with D2 + lymphadenectomy synchronously; (2) no distant metastasis (referring to extraperitoneal cavity metastases according to the 13th Edition of definition by the Japanese Research Society for Gastric Cancer (JRSGC); (3) complete clinical data and followup information; (4) the causes of death were tumor metastasis and recurrence. Of the 630 patients, 480 were men and 150 were women with a ratio of 3.2:1. The median age of the patients was 54.5 years (range, 2088 years The patients were followedup by letter and telephone till August 2009. All living patients were followed up for over 5 years. All patients had complete followup data.
Categorical data were analyzed by the 字 2 test. Multivariate prognostic analysis was performed using Cox proportional hazards model. The level of significance was set at < 0.05. Statistical analyses were performed with the SPSS13.0 software. The 1, 3, and 5year overall survival (OS) rates were 63.8%, 31.4%, 14.3% in the whole group, respectively. Univariate analysis showed that lymphatic metastasis, organ invasion, tumor location, tumor size, Borrmann type, and pathologic type were significantly associated with 1year survival rate ( < 0.05); Borrmann type, lymphatic metastasis, organ invasion and pathologic type were significantly associated with 3year survival rate ( < 0.05); Borrmann type, organ invasion and pathologic type were significantly associated with 5year survival rate ( < 0.05) ( Table 1 ).
The 1, 3, and 5year OS rates were 69.8% , 39.1%, 18.3% in patients treated with radical resection, and 56.8% , 22.6% , 9.6% in patients treated with nonradical operation ( < 0.05). The 1, 3, and 5year OS rates were 71.4% , 34.6% , 14.8% in patients treated with combined organ resection, and 58.8% , 30.0% , 14.2% in patients treated without combined organ resection, with significant difference in 1year OS rates between the two groups ( < 0.05), but no significant difference in 3 and 5year OS rates was found ( > 0.05). The scope of gastric resection had no relationship with prognosis ( > 0.05) ( Table 2) .
Cox multivariate prognostic analysis showed that lymphatic metastasis, organ invasion, Borrmann type, pathologic type, and radical resection were independent prognostic factors for 1year survival; pathologic type, lymphatic metastasis and organ invasion were independent prognostic factors for 3year survival; only pathologic type was an independent prognostic factor for 5year survival (Tables 35). To date, the proportion of patients with stage IV gastric cancer in all gastric cancer patients is still high. With the carrying out of standard radical gastrectomy and extended radical gastrectomy, the prognosis of early gastric cancer and resectable advanced gastric cancer has been significantly improved. For stage IV gastric cancer, people try to improve the prognosis by expanding the scope of lymphadenectomy and combined organ resection, but have achieved no remarkable results. At present, most experts believe that treatment of gastric cancer should be based on a reasonable choice of operation pattern and treatment methods [46] . Stage IV gastric cancer has its own clinicopathologic features. Our study showed that only pathologic type was an independent prognostic factor for 5year survival rate: the prognosis of papillary adenocarcinoma, tubular adenocarcinoma and poorly differentiated adenocarcinoma was better than that of signetring cell carcinoma and mucinous adenocarcinoma. Papillary adenocarcinoma and tubular adenocarcinoma are usually well differentiated, with low malignancy and slow disease progression. Although poorly differentiated adenocarcinoma has high malignancy, it is sensitive to radiotherapy and chemotherapy which could prolong survival in a certain period. Signetring cell carcinoma and mucinous adenocarcinoma are insensitive to radiotherapy and chemotherapy, progress rapidly, have poor prognosis. Lymphatic metastasis, organ invasion and radical gastrectomy were not prognostic factors for 5year survival rate, indicating that even using radical gastrectomy, expanding the scope of lymphadenectomy, and combining organ resection could prolong survival in a period, of time, and can hardly achieve truly radical resection, because exfoliated cells and occult distant metastasis are difficult to be found and eliminated. In this study, patients with Borrmann type 4 gastric cancer had shorter survival, with a 5year survival rate of 0. This may be related to that Borrmann type 4 gastric cancer is concealed and is difficult to be detected at early stage, and shows infiltrative growth, often has micrometastasis in the gastric wall. Seven patients with T1 gastric cancer had extensive metastasis, 6 of them died within 1 year after operation, suggesting that the scope of lymphadenectomy for early gastric cancer could not be blindly reduced. When level III lymph node metastasis is found, expanding the scope of lymphadenectomy could not significantly increase 5year survival rate [7] . In fact, that extensive lymph node dissection (ELND) increases the survival rate is due to the socalled 耶stageshifting phenomenon爷, which increases staging by ELND, improves stagespecific survival rate, but could not improve overall survival rate [8] . Extended lymphadenectomy significantly increases postoperative complications [9] . Therefore, the scope of lymphadenectomy should be decided based on an accurate preoperative and intraoperative assessment rather than blindly expanded.
In this study, the 5year OS rate was significantly higher in radical resection group than in nonradical resection group, the 1year OS rate was significantly higher in patients treated with combined organ resection than in those without combined organ resection. Therefore, we advocate that the scope of resection should be expanded as long as patients could tolerate to create chances for subsequent nonsurgical treatment and improve the efficacy. Recently, we treated some gastric cancer patients with surrounding organ invasion and retroperitoneal lymph node metastasis by 23 courses of neoadjuvant chemotherapy, and achieved downstaging effect. Meanwhile, we observed that some patients treated with standard postoperative chemotherapy achieved complete remission, and shortterm efficacy was significantly improved.
Gockel . [10] found that there was no significant difference in 5year survival rate between the patients with gastric cardia carcinoma treated by proximal gastric resection and total gastrectomy, while perioperative mortality of total gastrectomy group was increased significantly. Under these circumstances, we consider to prolong patients爷 survival by improving the quality of life. In view of this problem, we carried out proximal gastrectomy with single loop jejunal interposition for cardia cancer and cardiareserved proximal gastrectomy for gastric cancer with a distance of more than 5 cm from the cardia, and achieved certain effect on improving the nutritional status and reducing reflux, but the effect on prolonging survival should be further observed [11] . To sum up, for stage IV gastric cancer, the selection of operation pattern, lymphadenectomy scope and combined organs resection should be based on lesion location, size, depth of invasion, organs invasion and lymph node metastasis to improve 5year survival rate. At the same time , to select reasonable methods of digestive tract reconstruction based on the patient's age and physical condition may help to improve the quality of life. 
